Suit By Patients, Zurich Over Actimmune Tossed
A federal judge has dismissed a suit by a putative class of patients and their insurer Zurich Insurance Co. alleging that biotechnology company InterMune Inc. fraudulently promoted its drug Actimmune as...To view the full article, register now.
Already a subscriber? Click here to view full article